XML 18 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows – Operating activities:    
Net earnings, including noncontrolling interests $ 38,284 $ 29,645
Adjustments to reconcile net earnings to net cash used by operating activities:    
Depreciation 24,505 24,600
Amortization of intangible and other assets 4,123 9,244
Tax deficiencies (excess tax benefits) from stock-based payment arrangements 45 (5,800)
Stock-based compensation 15,957 9,095
Foreign currency and other non-cash adjustments 11,496 28,539
Change in assets and liabilities, net of acquisition:    
Accounts receivable, net 89,649 59,396
Inventories, net (69,863) (117,848)
Prepaid expenses and other 2,904 (22,781)
Other assets, net (9,095) (2,330)
Accounts payable (89,487) (131,208)
Accrued liabilities and income taxes payable (17,374) 2,698
Retirement obligations and other 844 14,432
Net deferred taxes (9,984) 9,117
Net cash flows used by operating activities (7,996) (93,201)
Cash flows – Investing activities:    
Capital expenditures (20,212) (83,967)
Payments for acquisition, net of cash acquired 0 (341,545)
Proceeds from disposal of assets 101 1,649
Net cash flows used by investing activities (20,111) (423,863)
Cash flows – Financing activities:    
(Tax deficiencies) excess tax benefits from stock-based payment arrangements (45) 5,800
Payments on long-term debt (15,000) (10,000)
Proceeds from issuance of senior notes 0 523,418
Payments of deferred loan cost 0 (1,005)
Proceeds under other financing arrangements 14,009 7,190
Payments under other financing arrangements (11,017) (5,207)
Repurchases of common shares 0 (79,899)
Payments of dividends (23,415) (21,686)
Other (142) 264
Net cash flows (used) provided by financing activities (35,610) 418,875
Effect of exchange rate changes on cash 7,591 (18,385)
Net change in cash and cash equivalents (56,126) (116,574)
Cash and cash equivalents at beginning of period 366,444 450,350
Cash and cash equivalents at end of period $ 310,318 $ 333,776